31.42USD-5.79%Mkt Cap: 3.22B USDP/E: —Last update: 2026-06-01
Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. Its programs in hematology and genetic disease…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap3.22B USD
Enterprise Value2.32B USD
Revenue (TTM)164.01M USD
Gross Profit-240.93M USD
Net Income (TTM)-79.99M USD
Revenue/Share1.597 USD
Last Price31.42 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees522
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.94
PEG—
EV/EBITDA-6.63
EV/Revenue14.13
P/S20.66
P/B2.81
EPS (TTM)-0.49
EPS (Forward)-4.74
52W Range
15.3576% of range36.44
52W High36.44 USD
52W Low15.35 USD
Profitability
Gross Margin-146.90%
Oper. Margin-337.81%
EBITDA Margin-212.94%
Profit Margin-57.24%
ROE-6.46%
ROA-5.40%
Growth
Revenue Growth324.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-345.10M USD
CapEx (TTM)14.95M USD
FCF Margin-142.40%
FCF Yield-7.26%
Net Debt-960.83M USD
Net Debt/EBITDA2.75
Balance Sheet
Debt/Equity0.12
Current Ratio16.99
Quick Ratio16.25
Book Value/Sh11.71 USD
Cash/Share12.17 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)51.07 USD
Target Range26.00 USD – 80.00 USD
# Analysts15
Ownership
Shares Out.102.88M
Float87.97M
Insiders1.36%
Institutions107.04%
Short Interest
Short Ratio12.2d
Short % Float39.93%
Short % Out.25.77%
Shares Short26.52M
Short (prev mo.)22.22M
Technical
SMA 5028.17 (+11.5%)
SMA 20025.94 (+21.1%)
Beta2.26
S&P 52W Chg27.94%
Avg Vol (30d)1.97M
Avg Vol (10d)1.93M
Technical Indicators
RSI (14)63.2
MACD0.6244
MACD Signal0.2694
MACD Hist.+0.3550
BB Upper34.57 USD
BB Middle30.15 USD
BB Lower25.72 USD
BB Width29.35%
ATR (14)1.960 USD
Vol Ratio (20d)0.38x